Authors: Barbara A Bennett, Charlotte K Hollingsworth, R.Shayn Martin, Steven R Childers, Richard E Ehrenkaufer, Linda J Porrino, Huw M.L Davies
Neuropharmacology,
1998, 37, 1, 123-130
68. Alterations in behavior and opioid gene expression induced by the novel tropane analog WF-31
Authors: James B. Daunais, Stephanie L. Hart, Ashlee Hedgecock-Rowe, Julius J. Matasi, Craig Thornley, Huw M.L. Davies, Linda J. Porrino
Molecular Brain Research
1997, 50, 1-2, 293-304
67. Local cerebral metabolic effects of the novel cocaine analog, WF-31: Comparisons to fluoxetine
Authors: Linda J. Porrino, Mack Miller, Ashlee A. Hedgecock, Craig Thornley, Julius J. Matasi, Huw M.L. Davies
Synapse
1997, 27, 1, 26-35
55. Synthesis of 3β-Aryl-8-azabicyclo[3.2.1]octanes with High Binding Affinities and Selectivities for the Serotonin Transporter Site
Authors: Huw M. L. Davies , Lisa A. Kuhn , Craig Thornley , Julius J. Matasi , Tammy Sexton, and Steven R. Childers
J. Med. Chem.,
1996, 39 (13), 2554–2558
48. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.
Authors: B A Bennett, C H Wichems, C K Hollingsworth, H M Davies, C Thornley, T Sexton and S R Childers
J. Pharmacol. Exp. Therap.,
1995, 272, 3, 1176-1186
40. Synthesis of 2.beta.-Acyl-3.beta.-aryl-8-azabicyclo[3.2.1]octanes and Their Binding Affinities at Dopamine and Serotonin Transport Sites in Rat Striatum and Frontal Cortex
Authors: Huw M. L. Davies , Elie Saikali , Nicholas J. S. Huby , Vernon J. Gilliatt , Julius J. Matasi , Tammy Sexton , Steven R. Childers
J. Med. Chem.,
1994, 37 (9), 1262–1268